跳转至内容
Merck

Putative tumor suppression function of SIRT6 in endometrial cancer.

FEBS letters (2015-07-18)
Tomohiko Fukuda, Osamu Wada-Hiraike, Katsutoshi Oda, Michihiro Tanikawa, Chinami Makii, Kanako Inaba, Aki Miyasaka, Yuichiro Miyamoto, Tetsu Yano, Daichi Maeda, Takeshi Sasaki, Kei Kawana, Masashi Fukayama, Yutaka Osuga, Tomoyuki Fujii
摘要

SIRT6, a member of the sirtuin family, has been identified as a candidate tumor suppressor. To pursue the role of SIRT6 in endometrial cancer, we investigated the anti-tumorigenic function of SIRT6. The expression of SIRT6 negatively affected the proliferation of AN3CA and KLE endometrial cancer cells. Increased expression of SIRT6 resulted in the induction of apoptosis by repressing the expression of the anti-apoptotic protein survivin. Consistent with this result, a survivin inhibitor YM155 efficiently inhibited cellular proliferation and induced apoptosis. These results revealed that SIRT6 might function as a tumor suppressor of endometrial cancer cells.

材料
货号
品牌
产品描述

Sigma-Aldrich
荧光素 5(6)-异硫氰酸酯, BioReagent, suitable for fluorescence, mixture of 2 components, ≥90% (HPLC)
Sigma-Aldrich
荧光素 5(6)-异硫氰酸酯, ≥90% (HPLC)
Sigma-Aldrich
荧光素异硫氰酸酯异构体I, ≥97.5% (HPLC)
Sigma-Aldrich
荧光素异硫氰酸酯异构体I, ≥97.5% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Sirt6
Sigma-Aldrich
MISSION® esiRNA, targeting human SIRT6